BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 179130)

  • 1. mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. I. Clinical aspects.
    Jonsson V; Videbek A; Axelsen NH; Harboe M
    Scand J Haematol; 1976 Mar; 16(3):209-17. PubMed ID: 179130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. II. Immunochemical studies.
    Axelsen NH; Harboe M; Jonsson V; Videbaek AA
    Scand J Haematol; 1976 Mar; 16(3):218-25. PubMed ID: 179131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-chain disease.
    Franklin EC
    Arch Intern Med; 1975 Jan; 135(1):71-2. PubMed ID: 1111471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mu-heavy chain disease associated with systemic amyloidosis.
    Kinoshita K; Yamagata T; Nozaki Y; Sugiyama M; Ikoma S; Funauchi M; Kanamaru A
    Hematology; 2004 Apr; 9(2):135-7. PubMed ID: 15203869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete variable region deletion in a mu heavy chain disease protein (ROUL). Correlation with light chain secretion.
    Cogné M; Aucouturier P; Brizard A; Dreyfus B; Duarte F; Preud'homme JL
    Leuk Res; 1993 Jun; 17(6):527-32. PubMed ID: 8505850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunochemical properties of free mu-chain protein in a patient with mu-heavy chain disease].
    Tamura A; Yamashiro A; Mizutani F; Oita T; Maeda A; Takahashi T
    Rinsho Byori; 2003 Sep; 51(9):847-51. PubMed ID: 14560651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cast nephropathy in mu heavy chain disease.
    Preud'homme JL; Bauwens M; Dumont G; Goujon JM; Dreyfus B; Touchard G
    Clin Nephrol; 1997 Aug; 48(2):118-21. PubMed ID: 9285150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mu-chain disease. Report of two new cases.
    Brouet JC; Seligmann M; Danon F; Belpomme D; Fine JM
    Arch Intern Med; 1979 Jun; 139(6):672-4. PubMed ID: 109059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-induced switching of immunoglobulin heavy-chain class secretion in chronic B-lymphocytic leukaemia and immunocytoma cell populations.
    Juliusson G; Robèrt KH; Hammarström L; Smith CI; Biberfeld G; Gahrton G
    Scand J Immunol; 1983 Jan; 17(1):51-9. PubMed ID: 6405478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new case of heavy mu-chain disease.
    Danon F; Mihaesco C; Bouvry M; Clerc M; Seligmann M
    Scand J Haematol; 1975 Aug; 15(1):5-9. PubMed ID: 170667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lymphocytic leukaemia and IgG heavy chain disease.
    Briët E; van Nieuwkoop JA; Jol-vd Zijde CM; den Ottolander GJ; Rádl J
    Scand J Haematol; 1980 Sep; 25(3):244-50. PubMed ID: 7008181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies.
    Foroni L; Catovsky D; Rabbitts TH; Luzzatto L
    Mol Biol Med; 1984 Feb; 2(1):63-79. PubMed ID: 6439975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma (light chain disease) with rheumatoid-like amyloid arthropathy and mu-heavy chain fragment in the serum.
    Pruzanski W; Hasselback R; Katz A; Parr DM
    Am J Med; 1978 Aug; 65(2):334-41. PubMed ID: 99035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodular glomerulosclerosis secondary to mu heavy chain deposits.
    Liapis H; Papadakis I; Nakopoulou L
    Hum Pathol; 2000 Jan; 31(1):122-5. PubMed ID: 10665924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune phenotype and prognosis in chronic B-lymphocytic leukaemia and leukaemic immunocytoma.
    Juliusson G; Ost A; Biberfeld P; Robèrt KH; Gahrton G
    Acta Med Scand; 1985; 218(3):335-40. PubMed ID: 3878068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin mu-chain gene rearrangement in a patient with T cell acute lymphoblastic leukemia.
    Ha K; Minden M; Hozumi N; Gelfand EW
    J Clin Invest; 1984 Apr; 73(4):1232-6. PubMed ID: 6423668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu-chain disease.
    Lee SL; Rosner F; Ruberman W; Glasberg S
    Ann Intern Med; 1971 Sep; 75(3):407-14. PubMed ID: 5568152
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heavy chain diseases].
    Seligmann M
    Rev Prat; 1993 Feb; 43(3):317-20. PubMed ID: 8502962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some impacts of clinical investigation on immunology. Surface IgD, IgE, and heavy-chain variants.
    Franklin EC
    N Engl J Med; 1976 Mar; 294(10):531-7. PubMed ID: 814459
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of proliferation and differentiation of leukaemic B cells from patients with chronic lymphocytic leukaemia by anti-mu and conditioned medium.
    Steinberg J; Moore MA; Bernhardt B; Bona CA; Platsoucas CD
    Scand J Immunol; 1987 Jun; 25(6):599-611. PubMed ID: 3110941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.